Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers R > Headlines for Recipharm AB > News item |
Morning Commentary: Chesapeake plans new issue; price talk emerges on DTE deal; Recipharm on tap
By Stephanie N. Rotondo
Seattle, Sept. 29 – The new issues continued to flow into the convertible bond market on Thursday.
Chesapeake Energy Corp., for one, said it was offering $850 million of 10-year convertible senior notes via a Rule 144A offering.
The company plans to use the proceeds for general corporate purposes, which may include debt repurchases and repayment of near-term maturities.
Meanwhile, the market was also waiting for DTE Energy Co.’s $600 million sale of mandatory convertible tangible equity units, a deal first announced late Wednesday.
Pricing is expected later in the session. Price talk is 6.25% to 6.75%, with a conversion premium of 20% to 25%, according to a market source.
The $50-par units will hold a contract to purchase common stock and a 1/20th, or 5%, undivided beneficial ownership interest in a $1,000-par remarketable senior note.
Proceeds will be used for the purchase of midstream natural gas assets.
On the international stage, Recipharm AB said it planned to sell SEK 1 billion of senior unsecured convertible bonds due 2021.
Price talk is 2% to 2.75% with an initial conversion premium of 30% to 35%. Pricing is expected Thursday afternoon.
The Swedish drug manufacturer said it would use funds from the sale for growth opportunities.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.